| 1 |
Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity |
|
| | Perlaza, B.-L., Sauzet, J.-P., Brahimi, K., Benmohamed, L., Druilhe, P. | | | Malaria Journal. 2011; 10(art 27) | | | [Pubmed] [Google Scholar] | | | 2 |
Development of anti-malarial vaccines and need for clinical trials in accordance with international standards in South Africa | [Le développement de vaccins antipaludiques et la nécessité des essais cliniques conformes aux normes internationales en Afrique] |
|
| | Doumbo, O.K., Djimdé, A.A., Théra, M.A. | | | Bulletin de la Societe de Pathologie Exotique. 2008; 101(3): 249-253 | | | [Pubmed] [Google Scholar] | | | 3 |
Blood-stage challenge for malaria vaccine efficacy trials: A pilot study with discussion of safety and potential value |
|
| | Sanderson F, Andrews L, Douglas AD, et al. | | | AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2008; 78(6): 878-883 | | | [Pubmed] [Google Scholar] | | | 4 |
Novel vaccines and adjuvant systems - The utility of animal models for predicting immunogenicity in humans |
|
| | Davis HL | | | HUMAN VACCINES. 2008; 4(3): 246-250 | | | [Pubmed] [Google Scholar] | | | 5 |
Pre-erythrocytic stage malaria vaccines: time for a change in path |
|
| | Druilhe P, Barnwell JW | | | CURRENT OPINION IN MICROBIOLOGY. 2007; 10 (4): 371-378 | | | [Pubmed] [Google Scholar] | | | 6 |
Progress and challenges towards the development of malaria vaccines |
|
| | Tetteh KKA, Polley SD | | | BIODRUGS. 2007; 21 (6): 357-373 | | | [Pubmed] [Google Scholar] | |
|
